59-291 section 3 lecture 3 antiarrhythmic drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 ›...
TRANSCRIPT
![Page 1: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/1.jpg)
1
59-291 Section 3 Lecture 3
Antiarrhythmic Drugs
• Heart beats (HB) originate fromAV node
• Normal 70 beats/min at rest• Arrhythmia (dysrhythmia):
Abnormal origin, rhythm, or rate• Supraventricular arrhythmia:
arise in the atria or AV node• Ventricular arrhythmia: arise in
the ventricles• Tachyarrhythmia: HB too rapid• Bradyarrhythmia: HB too slow
Some arrhythmias are benign anddo not require treatment othersinterfere with cardiac output or BPor can cause more severe or lethalrhythm disturbances.
![Page 2: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/2.jpg)
2Resting membrane potential of a cardiac cell
Resting membrane potential (RMP): A net negative charge relative to the outside of acardiac cell
Action potential: Change in the distribution of ions across the cell membrane andpropagation of an electrical impulse and the subsequent contraction of myocardialcells. AP consist of 4 phases
Spontaneous depolarization is referred to automaticity or pacemaker activity
![Page 3: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/3.jpg)
3
P-wave:atrialdepolarization
PR: Time it takes for theaction potential toconduct through the atriaand the AV node
QRS wave: Ventricular depolarization
T wave: Ventricular repolarization
ECG –is a summation of theaction potentials generated bythe heartQT: time between
ventriculardepolarization andrepolarization
![Page 4: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/4.jpg)
4
Pacemaker cells
3 distinct phases:
0- rapid depolarization
3- repolarization
4- resting potential (unstable)
Non pacemaker cells5 distinct phases:
0- rapid depolarization
1-initial repolarization
2- action potential plateau
3- repolarization
4- resting potential (stable)
![Page 5: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/5.jpg)
5
+1400.0001 mM2 mMCa2+
-90150 mM4 mMK+
+5010 mM145 mMNa+
EquilibriumPotentialmV
InsideCell
Outside Cell
ion
Threshold potential (TP)
![Page 6: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/6.jpg)
6
![Page 7: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/7.jpg)
7
P-wave:atrialdepolarization
PR: Time it takes for theaction potential toconduct through the atriaand the AV node
QRS wave: Ventricular depolarization
T wave: Ventricular repolarization
ECG –is a summation of theaction potentials generated bythe heartQT: time between
ventriculardepolarization andrepolarization
![Page 8: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/8.jpg)
8
Pathophysiology of Arrhythmias
• Coronary ischemia and hypoxia• Electrolyte imbalance• Overstimulation of sympathetic NS• General anesthetics• Other conditions that perturb cardiac
conduction
![Page 9: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/9.jpg)
9
Abnormal impulse formation• Increased automaticity
• Decreased the required time for depolarization from themaximal diastolic potential (MDP) to the threshold potential
![Page 10: 59-291 Section 3 Lecture 3 Antiarrhythmic Drugsmutuslab.cs.uwindsor.ca › mutus › 59-291 › PDF_lectures_F2007 › 59 … · 59-291 Section 3 Lecture 3 Antiarrhythmic Drugs •Heart](https://reader036.vdocuments.us/reader036/viewer/2022081406/5f0ffbe07e708231d446dcd2/html5/thumbnails/10.jpg)
10
• Afterdepolarizations• Abnormal calcium influx into cardiac cells during or immediately after phase 3
of ventricular action potential